PneumoWave News / Blogs

Today is Opioid Awareness Day

Today is Opioid Awareness Day. Our Chief Executive Officer and Founder Dr Bruce Henderson has written a powerful opinion piece based on his direct clinical experience treating patients. Learn more about the human cost of the opioid epidemic and the compassion that addicts deserve.

Read More »

Dr Gary Cooney appointed as Mental Health Lead

Digital health company PneumoWave today announced the appointment of Dr Gary Cooney as Mental Health Lead, with responsibility for the planning and execution of addiction and other mental health-related treatment studies using PneumoWave’s technology platform for diagnosis and monitoring of respiratory changes.

Read More »

Rebrand of Altair Medical to PneumoWave

UK based Altair Medical today announced, as part of its ongoing growth story, that it is rebranding to PneumoWave. The name fully reflects the digital therapeutics platform that the company believes will transform respiratory healthcare. In a key step towards commercial launch of the platform, a multi-centre program of clinical trials is currently underway in leading academic and healthcare institutions.

Read More »

Altair Medical secures $3.1m in Pre-Series A financing

UK based Altair Medical today announced it has secured £2.25m ($3.1m) of Pre-Series A funding to further develop its respiratory sensor and real-time monitoring platform. The service uses AI to detect and alert to adverse events from a range of breathing problems, with the hope of preventing a large number of early deaths.

Read More »